目的 了解抗感冒中成藥藥物經(jīng)濟(jì)學(xué)評(píng)價(jià)的研究現(xiàn)狀，分析存在的問(wèn)題并提出相關(guān)建議。方法 通過(guò)檢索中國(guó)期刊全文數(shù)據(jù)庫(kù)（CNKI）、中文科技期刊全文數(shù)據(jù)庫(kù)（VIP）、萬(wàn)方數(shù)據(jù)庫(kù)、Pubmed數(shù)據(jù)庫(kù)，納入從建庫(kù)至2017年6月所有抗感冒中成藥的藥物經(jīng)濟(jì)學(xué)評(píng)價(jià)文獻(xiàn)，將信息輸入Microsoft Excel（2010版）軟件進(jìn)行系統(tǒng)分析與評(píng)估。結(jié)果 根據(jù)納入與排除標(biāo)準(zhǔn)，共獲取符合要求的文獻(xiàn)21篇，結(jié)果發(fā)現(xiàn)存在研究角度不明確、回顧性研究居多、目標(biāo)人群的納入排除標(biāo)準(zhǔn)不嚴(yán)謹(jǐn)、研究時(shí)限偏短、分析技術(shù)不合理、模型應(yīng)用少、成本測(cè)算不全面、產(chǎn)出指標(biāo)未能體現(xiàn)中藥特色、療效判定不嚴(yán)謹(jǐn)?shù)葐?wèn)題。結(jié)論 目前對(duì)抗感冒中成藥藥物經(jīng)濟(jì)學(xué)評(píng)價(jià)的探索相對(duì)較少，文獻(xiàn)質(zhì)量普遍偏低，研究方法尚待規(guī)范。

Objective To investigate the current status of pharmacoeconomics evaluation about anti-cold Chinese Patent Medicine and analyze the existing problems and put forward related suggestions. Methods By searching CNKI, VIP, Wanfang database, and Pubmed database, pharmacoeconomics literatures about anti-cold Chinese Patent Medicine published from the database building to June 2017 were included. The information were input into Microsoft Excel (2010 version) for system analysis and evaluation. Results According to the inclusion and exclusion criteria, a total of 21 papers that meet the requirements were obtained. There are some problems found in these papers, in which the study perspective was not clear, mostly were retrospective studies, the inclusion and exclusion criteria of target population was not rigorous, the study time was short, the analysis technical was unreasonable, less model application, the cost was not comprehensive, the effect indicator failed to reflect the characteristics of TCM, and the curative effect judgment was loose. Conclusions At present, the research of pharmacoeconomics evaluation about anti-cold Chinese Patent Medicine is relatively few, the quality of such studies is generally low and the research methods have yet to be standardized.